These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8837610)

  • 21. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
    Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.
    Li Z; Wang S; Wu Y; Zhong G; Chen D
    Sci China C Life Sci; 2008 Nov; 51(11):973-80. PubMed ID: 18989639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.
    Wang J; Chen L; Chen F; Zhang X; Zhang Y; Baseman J; Perdue S; Yeh IT; Shain R; Holland M; Bailey R; Mabey D; Yu P; Zhong G
    Vaccine; 2009 May; 27(22):2967-80. PubMed ID: 19428908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
    He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
    Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.
    Eko FO; Lubitz W; McMillan L; Ramey K; Moore TT; Ananaba GA; Lyn D; Black CM; Igietseme JU
    Vaccine; 2003 Apr; 21(15):1694-703. PubMed ID: 12639492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection.
    Ghaem-Maghami S; Ratti G; Ghaem-Maghami M; Comanducci M; Hay PE; Bailey RL; Mabey DC; Whittle HC; Ward ME; Lewis DJ
    Clin Exp Immunol; 2003 Jun; 132(3):436-42. PubMed ID: 12780690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans.
    Wang J; Zhang Y; Lu C; Lei L; Yu P; Zhong G
    J Immunol; 2010 Aug; 185(3):1670-80. PubMed ID: 20581152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.
    Coler RN; Bhatia A; Maisonneuve JF; Probst P; Barth B; Ovendale P; Fang H; Alderson M; Lobet Y; Cohen J; Mettens P; Reed SG
    FEMS Immunol Med Microbiol; 2009 Mar; 55(2):258-70. PubMed ID: 19281568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
    Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
    Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide identification of Chlamydia trachomatis antigens associated with trachomatous trichiasis.
    Lu C; Holland MJ; Gong S; Peng B; Bailey RL; Mabey DW; Wu Y; Zhong G
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2551-9. PubMed ID: 22427578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody signature of spontaneous clearance of Chlamydia trachomatis ocular infection and partial resistance against re-challenge in a nonhuman primate trachoma model.
    Kari L; Bakios LE; Goheen MM; Bess LN; Watkins HS; Southern TR; Song L; Whitmire WM; Olivares-Zavaleta N; Caldwell HD
    PLoS Negl Trop Dis; 2013; 7(5):e2248. PubMed ID: 23738030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.
    Jiang P; Du W; Xiong Y; Lv Y; Feng J; Zhu S; Xue X; Chen S; Zhang L
    Oncotarget; 2015 Dec; 6(41):43281-92. PubMed ID: 26657117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteome array of antibody responses to Chlamydia trachomatis infection in nonhuman primates.
    Lu C; Sun Z; Chen H; Chen L; Zhu C; Chen C; Li C; Peng B; Zhong G
    Life Sci; 2020 May; 248():117444. PubMed ID: 32084433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination with MIP or Pgp3 induces cross-serovar protection against chlamydial genital tract infection in mice.
    Luan X; Peng B; Li Z; Tang L; Chen C; Chen L; Wu H; Sun Z; Lu C
    Immunobiology; 2019 Mar; 224(2):223-230. PubMed ID: 30558842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Vaccine; 1997 Apr; 15(5):575-82. PubMed ID: 9160528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.
    Zhang YX; Stewart S; Joseph T; Taylor HR; Caldwell HD
    J Immunol; 1987 Jan; 138(2):575-81. PubMed ID: 3540122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge.
    Picard MD; Cohane KP; Gierahn TM; Higgins DE; Flechtner JB
    Vaccine; 2012 Jun; 30(29):4387-93. PubMed ID: 22682294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice.
    Pal S; Peterson EM; de la Maza LM
    Immunology; 2003 Nov; 110(3):368-75. PubMed ID: 14632665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates.
    Vasilevsky S; Stojanov M; Greub G; Baud D
    Virulence; 2016; 7(1):11-22. PubMed ID: 26580416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection.
    Wang L; Cai Y; Xiong Y; Du W; Cen D; Zhang C; Song Y; Zhu S; Xue X; Zhang L
    Oncotarget; 2017 May; 8(20):33241-33251. PubMed ID: 28402260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.